Effects of Glycemic Control on Hearing Outcomes in Diabetes Patients With Idiopathic Sudden Sensorineural Hearing Loss
- Authors
- Park, Euyhyun; Shim, Jaehyun; Choi, Soo Jeong; Jung, Hak Hyun; Im, Gi Jung
- Issue Date
- 3월-2021
- Publisher
- AVES
- Keywords
- Sudden sensorineural hearing loss; diabetes mellitus; glycemic control; hearing outcomes; prognostic factor
- Citation
- JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY, v.17, no.2, pp.109 - 114
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
- Volume
- 17
- Number
- 2
- Start Page
- 109
- End Page
- 114
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/137774
- DOI
- 10.5152/JIAO.2021.9276
- ISSN
- 1308-7649
- Abstract
- OBJECTIVE: This study aimed to analyze the effects of glycemic control on the hearing outcomes of type 2 diabetes patients with idiopathic sudden sensorineural hearing loss (ISSHL). METHODS: Type 2 diabetes patients with ISSHL were enrolled. All patients were admitted for 5 days and received systemic corticosteroid treatment. Patients were divided into groups according to their degree of glycemic control pre- (glycosylated hemoglobin) and post- (mean blood glucose) onset of ISSHL. Demographic, audiometric, and hearing outcome data were analyzed. Furthermore, a multivariate analysis was performed to determine the prognostic factors affecting the hearing outcomes in these patients. RESULTS: One hundred forty-four patients were enrolled. The hearing recovery rates were as follows: complete recovery, 19%; partial recovery, 15%; slight improvement, 22%; and no improvement, 44%. Initial hearing levels and diabetes duration were significantly higher in the pre-onset poor-controlled group (glycosylated hemoglobin >= 7.0%) than those in the well-controlled group. The hearing recovery rates did not differ significantly pre- or post-onset. In a multivariate analysis, duration from hearing loss onset to treatment, presence of vertigo, and initial hearing level were negative prognostic factors that affected hearing recovery. CONCLUSION: The degree of pre- or post-onset glycemic control did not affect hearing outcomes in patients with ISSHL and type 2 diabetes. Therefore, the administration of systemic corticosteroid is required for diabetes patients with ISSHL within allowable blood glucose levels.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.